• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    23.40 Down 0.53(2.21%) 3:55PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:23.93
    Open:23.51
    Bid:23.45 x 100
    Ask:23.50 x 300
    1y Target Est:39.60
    Beta:3.513
    Next Earnings Date:N/A
    Day's Range:22.90 - 23.82
    52wk Range:16.51 - 40.98
    Volume:178,896
    Avg Vol (3m):285,087
    Market Cap:799.41M
    P/E (ttm):N/A
    EPS (ttm):-0.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EPZM

    Comparison

    Symbol% ChgMkt Cap
    EPZMDown 2.21%799.41M
    GSKDown 0.50%114.72B
    NVSDown 0.97%237.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.13
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.75
    Quarterly EPS Est (Dec-14) :-0.53
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops personalized therapeutics for patients with genetically defined cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback